Envoyer à un ami

New protocol including the use of ALLEVYN™ LIFE reduces hospital-acquired pressure ...

- 6 Juillet 2016 modifié le 1 Janvier 1970

(BUSINESS WIRE)-- Smith & Nephew (LSE:SN)(NYSE:SNN), the global medical technology business, announces the publication of a new research paper showing how a comprehensive ulcer prevention programme which included the use of ALLEVYN™ LIFE can significantly decrease hospital-acquired pressure ulcers (HAPUs).1

The study was conducted in an adult intensive care unit (ICU) at Eskenazi Health, Indianapolis, Indiana, US, between 2012 and 2013, and published in the American Journal of Critical-Care Nurses.

The research emphasises that hospitals who adopt a standardised protocol for the prevention and treatment of HAPUs may see potential cost benefit of such prevention. At the end of the first year, the prevention programme demonstrated a 69% decrease in HAPUs.1 The estimated potential cost saving for the Eskenazi Health ICU was nearly $1 million, and the convincing results in the ICU have led to the approval of a hospital-wide rollout of the HAPU prevention programme. ...

Source :